|
|
||||||||
,
,
,
,||,1
* The Computer Science and Artificial Intelligence Laboratory, Cambridge, Massachusetts 02139; and
The Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and
The Department of Medicine, Brigham and Womens Hospital, Boston, Massachusetts 02115; and
The Division of Cardiovascular Disease, Brigham & Womens Hospital, Boston, Massachusetts 02115; and || The Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
To whom requests for reprints should be addressed at 1 MIT, The Stata Center, 32310, 32 Vassar Street, Cambridge, MA 02139. E-mail: cmstultz{at}mit.edu
Activation of the innate immune response in diseases such as rheumatoid arthritis and atherosclerosis leads to the production of proinflammatory cytokines that can promote collagenolysis. While a number of studies suggest that inflammation plays a major role in initiating collagen degradation, the effect of collagen and collagen-degradation fragments on the inflammatory response is not well understood. We now demonstrate that different collagen fragments can either augment or suppress IL-1ß production from human peripheral-blood monocytes. These data have wide-ranging implications for how amino acid variation in collagen affects disease and suggest that collagen degradation leads to the production of peptides that can modulate inflammation.
Key Words: collagen cytokines inflammation interleukin-1
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |